Merck DCF Stock Analysis. Buy or Sell?

Merck DCF Stock Analysis.

In partnership with

Want to get the most out of ChatGPT?

ChatGPT is a superpower if you know how to use it correctly.

Discover how HubSpot's guide to AI can elevate both your productivity and creativity to get more things done.

Learn to automate tasks, enhance decision-making, and foster innovation with the power of AI.

Merck DCF Stock Analysis

Here’s my assumptions for $MRK ( ▲ 0.34% ) :

Risk Free Rate (10 Years Interest Rate Swap): 4.1%

Risk Premium (Taken from the Aswath Damodaran equity premium spreadsheet): 4.33%

Interest Rate Spread on The Risk free rate ( For the cost of debt calculation): 1%

Historical Data

Revenue growth in the last 10 years (CAGR): 4.97%

Earnings growth in the last 10 years (CAGR): 14.44%

Unlevered Free Cash Flow growth in the last 10 years (CAGR): 4.39%

Future Assumptions

End of Year FCF growth: 3%

Growth until end of 2026: 4%

Growth until end of 2034: 3%

Perpetual growth: 2.5%

Net Debt: 25.616B

Restricted Stock Units Present Value Assumption: $0.998B

Stock Valuation based on these assumptions: $171

Last update 08/11/2025

All the content in this newsletter should be taken as informational content only. THIS IS NOT FINANCIAL ADVICE! Do your own Due Diligence before investing or contact a professional financial advisor.

I don’t have a position in Merck (MRK) and I don’t plan to add a position in the coming days.